Murine host response to Neisseria gonorrhoeae upper genital tract infection reveals a common transcriptional signature, plus distinct inflammatory responses that vary between reproductive cycle phases
Abstract Background The emergence of fully antimicrobial resistant Neisseria gonorrhoeae has led global public health agencies to identify a critical need for next generation anti-gonococcal pharmaceuticals. The development and success of these compounds will rely upon valid pre-clinical models of g...
Main Authors: | Ian P. Francis, Epshita A. Islam, Adam C. Gower, Yazdani B. Shaik-Dasthagirisaheb, Scott D. Gray-Owen, Lee M. Wetzler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | BMC Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12864-018-5000-7 |
Similar Items
-
Future Prospects for Neisseria gonorrhoeae Treatment
by: Beatriz Suay-García, et al.
Published: (2018-06-01) -
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada
by: I. Martin, et al.
Published: (2016-01-01) -
Cephalosporin resistance in Neisseria gonorrhoeae
by: Manju Bala, et al.
Published: (2010-01-01) -
Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain
by: Monica M. Lahra, et al.
Published: (2018-04-01) -
Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae
by: Claire C. Bristow, et al.
Published: (2016-05-01)